Mesirow Financial Investment Management - Fixed Income’s PRA Health Sciences, Inc. PRAH Stock Holding History

Mesirow Financial Investment Management - Fixed Income’s Portfolio PRAH Stock Details PRAH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-12,555	Closed	-$1.22M	–	150
2020 Q2	$1.22M	Buy	12,555 +4,230	+51%	+$394K	0.22%	111
2020 Q1	$691K	Sell	8,325 -6,355	-43%	-$620K	0.16%	109
2019 Q4	$1.63M	Buy	14,680 +2,210	+18%	+$227K	0.25%	97
2019 Q3	$1.24M	Buy	12,470 +50	+0.4%	+$4.96K	0.2%	102
2019 Q2	$1.23M	Buy	+12,420	New	+$1.19M	0.19%	103
2017 Q4	–	Sell	-235,722	Closed	-$18M	–	132
2017 Q3	$18M	Sell	235,722 -63,750	-21%	-$4.82M	1.18%	43
2017 Q2	$22.5M	Sell	299,472 -19,335	-6%	-$1.34M	1.51%	13
2017 Q1	$20.8M	Buy	+318,807	New	+$18.8M	1.38%	20

Other funds holding PRAH

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

NIPH

NN Investment Partners Holdings The Hague, Netherlands $18.6B AUM 18.31% 1-Year Est. Return

Pendal Group Sydney, Australia $11.6B AUM 12.87% 1-Year Est. Return

Mesirow Financial Investment Management - Fixed Income's PRAH Position: Q3 2020 in Review

Mesirow Financial Investment Management - Fixed Income sold out of PRA Health Sciences, Inc. (PRAH) in Q3 2020, closing a stake of 12,555 shares — an estimated $1.22M sold.

Mesirow Financial Investment Management - Fixed Income first reported a position in PRAH in Q1 2017 and held it in 8 quarters. The position peaked at $22.5M in Q2 2017. 281 funds tracked by Wall St. Rank hold PRAH as of Q3 2020.

Mesirow Financial Investment Management - Fixed Income reported no remaining PRA Health Sciences, Inc. position as of Q3 2020 after selling out during the quarter.
Mesirow Financial Investment Management - Fixed Income sold 12,555 PRA Health Sciences, Inc. shares in Q3 2020, an estimated $1.22M.
Mesirow Financial Investment Management - Fixed Income first reported a position in PRA Health Sciences, Inc. in Q1 2017 and held it in 8 quarters.
Mesirow Financial Investment Management - Fixed Income's PRA Health Sciences, Inc. position peaked at $22.5M in Q2 2017.
281 funds tracked by Wall St. Rank held PRA Health Sciences, Inc. as of Q3 2020.

Based on Mesirow Financial Investment Management - Fixed Income's 13F filing for Q3 2020, filed 5 Nov 2020.